Myelodysplasia: When to treat and how-Reference-Cited by-同舟云学术

Myelodysplasia: When to treat and how

Published:2006-06 Issue:2 Volume:19 Page:293-300
ISSN:1521-6926
Container-title:Best Practice & Research Clinical Haematology
language:en
Short-container-title:Best Practice & Research Clinical Haematology

Author:

Larson Richard A.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Oncology

Reference15 articles.

1. A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome;Saunthararajah;Blood,2003

2. Effects of influenza vaccination on mortality among frail, community-living elderly patients: an observational study;Landi;Aging Clin Exp Res,2003

3. Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias;Venugopal;Cancer Treat Res,2001

4. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997

5. Effects of treatment with 5-azacytidine on the in vivo and in vitro hematopoiesis in patients with myelodysplastic syndromes;Silverman;Leukemia,1993

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prise en charge des syndromes myélodysplasiques au Maroc à propos d´une étude mono-centrique;Pan African Medical Journal;2020

2. THREAT helps to identify epistaxis patients requiring blood transfusions;Journal of Otolaryngology - Head & Neck Surgery;2013-01-31

3. Venous Thromboembolism in Myelodysplastic Syndrome Patients Receiving Lenalidomide;Clinical Drug Investigation;2009

4. Treatment of myelodysplastic syndrome with 2 schedules and doses of oral topotecan;Cancer;2008-11-17

5. Allogeneic bone marrow transplantation and donor lymphocyte infusion in a mouse model of irradiation-induced myelodysplastic/myeloproliferation syndrome (MD/MPS): evidence for a graft-versus-MD/MPS effect;Leukemia;2008-11-06